SCHEMBL6091732

SCHEMBL6091732

Oc1cccc(OCCOc2ccccn2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.51
CHRNA4 P43681 1/20 0.51
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
DRD3 P35462 1/20 0.49
APP P05067 1/20 0.44
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
HTR1A P08908 1/20 0.40
MGLL Q99685 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1470185 0.82 CHRNB2 (0.69) CHRNB2CHRNA4ADRA1DADRA1AADRA1B
SCHEMBL29510932 0.82 CHRNB2 (0.69) CHRNB2CHRNA4ADRA1DADRA1AADRA1B
SCHEMBL10399922 0.81 DRD4 (0.47) DRD2DRD4DRD3APPNPC1
SCHEMBL30843232 0.81 TLR4 (0.50) APPMGLL
SCHEMBL2582155 0.81 TLR4 (0.50) APPMGLL
SCHEMBL10479366 0.81 DRD2 (0.63) CHRNB2CHRNA4ADRA1DADRA1AADRA1B
SCHEMBL6090065 0.79 CHRNB2 (0.50) CHRNB2CHRNA4ADRA1DADRA1AADRA1B
SCHEMBL4190714 0.78 KDM4E (0.50) NPC1ALDH1A1CYP2D6CYP2C19
SCHEMBL22964159 0.77 TLR4 (0.53) CHRNB2CHRNA4ADRA1DADRA1AADRA1B
SCHEMBL11231915 0.77 CHRNB2 (0.67) CHRNB2CHRNA4ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed